Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model

Caroline Sola, Fabien Chanuc, Ariane Thielens, Nicolas Fuséri, Yannis Morel, Mathieu Bléry, Pascale André, Éric Vivier, Robert F. Graziano, François Romagné,

Journal for ImmunoTherapy of Cancer · 2013 · 10 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

Meeting abstracts Natural Killer cells (NK cells) are lymphocytes able to recognize and kill tumors for which the expression of Major Histocompatibility Complex (MHC) class I molecules is altered. This “missing self” recognition is mediated in humans by the lack of engagement of MHC class I i.e